Cristina Alli
Rome, 00071, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Discovery and Optimization of IRBM-Z-2, an Allosteric Zika Virus NS2B-NS3 Protease Inhibitor Exhibiting In Vivo Efficacy.
Journal: Journal of medicinal chemistry
Published: May 29, 2026
Discovery and Preclinical Characterization of I-0436650, a Selective SHP2 Allosteric Inhibitor for RAS-Driven Cancers.
Journal: Journal of medicinal chemistry
Published: April 13, 2026
An allosteric inhibitor of the Zika virus NS2B-NS3 protease with oral efficacy in mouse models.
Journal: Nature communications
Published: May 15, 2025
Novel azabicyclic series of potent SHP2 allosteric inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: May 14, 2025
Direct-to-biology platform: From synthesis to biological evaluation of SHP2 allosteric inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: December 22, 2023
Discovery of a Novel Series of Potent SHP2 Allosteric Inhibitors.
Journal: ACS medicinal chemistry letters
Published: February 21, 2023
Discovery of a Novel Series of Imidazopyrazine Derivatives as Potent SHP2 Allosteric Inhibitors.
Journal: ACS medicinal chemistry letters
Published: October 21, 2022
Gametocyte-specific and all-blood-stage transmission-blocking chemotypes discovered from high throughput screening on Plasmodium falciparum gametocytes.
Journal: Communications biology
Published: February 09, 2022
Spiro-containing derivatives show antiparasitic activity against Trypanosoma brucei through inhibition of the trypanothione reductase enzyme.
Journal: PLoS neglected tropical diseases
Published: December 19, 2019
Molecular basis of USP7 inhibition by selective small-molecule inhibitors.
Journal: Nature
Published: March 23, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026